Table of Contents

1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer

About the Author

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.